Inhibition of CYP2D6-mediated tramadol O-demethylation in methadone but not buprenorphine maintenance patients.
about
The anti-addiction drug ibogaine and the heart: a delicate relationNew developments in the management of opioid dependence: focus on sublingual buprenorphine-naloxone.The Pharmacogenetics of Tramadol.Impact of fraction unbound, CYP3A, and CYP2D6 in vivo activities, and other potential covariates to the clearance of tramadol enantiomers in patients with neuropathic pain.Individual variability in clinical effect and tolerability of opioid analgesics - Importance of drug interactions and pharmacogenetics.
P2860
Inhibition of CYP2D6-mediated tramadol O-demethylation in methadone but not buprenorphine maintenance patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Inhibition of CYP2D6-mediated ...... norphine maintenance patients.
@ast
Inhibition of CYP2D6-mediated ...... norphine maintenance patients.
@en
type
label
Inhibition of CYP2D6-mediated ...... norphine maintenance patients.
@ast
Inhibition of CYP2D6-mediated ...... norphine maintenance patients.
@en
prefLabel
Inhibition of CYP2D6-mediated ...... norphine maintenance patients.
@ast
Inhibition of CYP2D6-mediated ...... norphine maintenance patients.
@en
P2093
P2860
P1476
Inhibition of CYP2D6-mediated ...... norphine maintenance patients.
@en
P2093
Aaron L Farquharson
Andrew A Somogyi
Heather M James
Janet K Coller
Jennifer R Michalakas
Joel Colvill
P2860
P304
P356
10.1111/J.1365-2125.2012.04256.X
P407
P577
2012-11-01T00:00:00Z